The antibody's effectiveness was tested in clinical trials where it showed it can prevent reoccurence of c.difficile in 10 to 15 percent of the cases.
Two former Merck virologists charged that Merck's MMR trial results were doctored in 2010.
09 Aug '24 16:35PM
